|
Onyx Pharmaceuticals Announces Proteasome Inhibitor Data Presentations at 14th International Myeloma Workshop
|
8:29 AM |
Apr 1, 2013 |
PR
|
|
Critical Alerts For Lowe's, Apollo Group, Darden Restaurants, Onyx Pharmaceuticals, and Ocwen Financial Released By InvestorsObserver
|
9:30 AM |
Mar 26, 2013 |
PR
|
|
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
|
9:02 AM |
Mar 26, 2013 |
Dow Jones Global News Select
|
|
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
|
6:37 AM |
Mar 26, 2013 |
Dow Jones Global News Select
|
|
Bayer's Stivarga(R) (regorafenib) Tablets -2-
|
5:16 PM |
Mar 25, 2013 |
PR
|
|
Bayer's Stivarga(R) (regorafenib) Tablets Approved in Japan
|
5:16 PM |
Mar 25, 2013 |
PR
|
|
Innovative Product Portfolios Ride Commercialization & Global Expansion - Research Report on Amgen, Onyx Pharmaceuticals, Alexion Pharmaceuticals, BioMarin Pharmaceutical and Incyte
|
8:01 AM |
Mar 18, 2013 |
PR
|
|
UPDATE: Onyx Pharmaceuticals CEO: Seeking Acquisition Targets
|
3:36 PM |
Mar 15, 2013 |
Dow Jones Global News Select
|
|
Onyx Pharmaceuticals CEO: Seeking Acquisition Targets
|
12:25 PM |
Mar 15, 2013 |
Dow Jones Global News Select
|
|
Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
|
8:01 AM |
Mar 14, 2013 |
PR
|
|
Drug Approvals, Breakthrough Treatments and Royalties - Research Report on Celgene Corporation, Onyx Pharmaceuticals, Sarepta Therapeutics, VIVUS and Achillion Pharmaceuticals
|
8:01 AM |
Mar 8, 2013 |
PR
|